Hims & Hers Health Cash Flow Statement
HIMS / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
Hims & Hers Health generated $300M in operating cash flow and $57M in free cash flow in FY2025. Free cash flow margin was 2.4% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income | $128.4M | $126.0M | -$23.5M | -$65.7M | -$107.7M | -$18.1M | -$72.1M |
| Depreciation & Amortization | $54.5M | $17.1M | $9.5M | $7.5M | $4.1M | $1.1M | $260.0K |
| Operating Cash Flow | $300.0M | $251.1M | $73.5M | -$26.5M | -$34.4M | -$2.5M | -$74.9M |
| Capital Expenditures | $242.6M | $52.8M | $26.5M | $7.2M | - | - | - |
| Free Cash Flow | $57.4M | $198.3M | $47.0M | -$33.7M | - | - | - |
| Share Buybacks | $90.0M | $83.0M | $2.0M | $0 | $0 | $0 | $0 |
| FCF Margin | 2.5% | 13.4% | 5.4% | -6.4% | - | - | - |